Bluejay Diagnostics Statistics Share Statistics Bluejay Diagnostics has 1.49M
shares outstanding. The number of shares has increased by -90.97%
in one year.
Shares Outstanding 1.49M Shares Change (YoY) -90.97% Shares Change (QoQ) 170.27% Owned by Institutions (%) 0.02% Shares Floating 1.49M Failed to Deliver (FTD) Shares n/a FTD / Avg. Volume n/a
Short Selling Information The latest short interest is 106.4K, so 7.12% of the outstanding
shares have been sold short.
Short Interest 106.4K Short % of Shares Out 7.12% Short % of Float 7.13% Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -0.12 and the forward
PE ratio is -0.01.
Bluejay Diagnostics's PEG ratio is
0.
PE Ratio -0.12 Forward PE -0.01 PS Ratio 0 Forward PS n/a PB Ratio 0.16 P/FCF Ratio -0.11 PEG Ratio 0
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Bluejay Diagnostics.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 6.05,
with a Debt / Equity ratio of 0.04.
Current Ratio 6.05 Quick Ratio 6.05 Debt / Equity 0.04 Debt / EBITDA -0.03 Debt / FCF -0.03 Interest Coverage -8.71
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-1.1M Employee Count 7 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by null% in the
last 52 weeks. The beta is 0.48, so Bluejay Diagnostics's
price volatility has been higher than the market average.
Beta 0.48 52-Week Price Change n/a 50-Day Moving Average 1.48 200-Day Moving Average 2.62 Relative Strength Index (RSI) 61.59 Average Volume (20 Days) n/a
Income Statement
Revenue n/a Gross Profit -199.1K Operating Income -7.17M Net Income -7.72M EBITDA -6.7M EBIT -6.89M Earnings Per Share (EPS) -42.08
Full Income Statement Balance Sheet The company has 4.3M in cash and 222.25K in
debt, giving a net cash position of 4.08M.
Cash & Cash Equivalents 4.3M Total Debt 222.25K Net Cash 4.08M Retained Earnings -34.67M Total Assets 6.4M Working Capital 3.71M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -7.82M
and capital expenditures -306.78K, giving a free cash flow of -8.13M.
Operating Cash Flow -7.82M Capital Expenditures -306.78K Free Cash Flow -8.13M FCF Per Share -44.31
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
Dividends & Yields BJDX does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast Currently there are no analyst rating for BJDX.
Price Target n/a Price Target Difference n/a Analyst Consensus n/a Analyst Count n/a
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Nov 18, 2024. It was a
backward
split with a ratio of 1:50.
Last Split Date Nov 18, 2024 Split Type backward Split Ratio 1:50
Scores Altman Z-Score -9.97 Piotroski F-Score 1
